Elanco Animal Health Incorporated (ELAN) financial statements (2021 and earlier)

Company profile

Business Address 2500 INNOVATION WAY
GREENFIELD, IN 46140
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments495334475
Cash and cash equivalents495334475
Restricted cash and investments1111203
Receivables1,077890709
Inventory, net of allowances, customer advances and progress billings1,5781,0511,004
Inventory1,5781,0511,004
Other undisclosed current assets25687114
Total current assets:3,4172,3732,505
Noncurrent Assets
Property, plant and equipment1,316955922
Intangible assets, net (including goodwill)12,6125,4725,411
Goodwill6,2252,9902,958
Intangible assets, net (excluding goodwill)6,3872,4832,453
Other noncurrent assets348185103
Other undisclosed noncurrent assets  15
Total noncurrent assets:14,2766,6136,452
TOTAL ASSETS:17,6938,9868,957
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities645322304
Accounts payable501223205
Employee-related liabilities14410099
Deferred revenue295211
Debt5552529
Due to related parties516 
Contract with customer, liability170
Other liabilities577244199
Other undisclosed current liabilities  269
Total current liabilities:2,076819971
Noncurrent Liabilities
Long-term debt and lease obligation5,5722,3312,443
Long-term debt, excluding current maturities5,5722,3312,443
Liabilities, other than long-term debt1,568290231
Deferred income tax liabilities900101
Liability, pension and other postretirement and postemployment benefits34683109
Other liabilities322107122
Other undisclosed noncurrent liabilities  115
Total noncurrent liabilities:7,1412,6202,789
Total liabilities:9,2173,4393,759
Stockholders' equity
Stockholders' equity attributable to parent8,4765,5475,198
Additional paid in capital8,6505,6365,403
Accumulated other comprehensive income (loss)303(174)(222)
Retained earnings (accumulated deficit)(477)8416
Total stockholders' equity:8,4765,5475,198
TOTAL LIABILITIES AND EQUITY:17,6938,9868,957

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Revenues3,2733,0713,067
Cost of revenue(1,667)(1,577)(1,645)
Cost of goods and services sold(1,667)(1,470)(1,574)
Gross profit:1,6071,4941,422
Operating expenses(2,307)(1,416)(1,308)
Operating income (loss):(701)78114
Nonoperating income (expense)178(27)(41)
Interest and debt expense(150)(79)(30)
Income (loss) from continuing operations before equity method investments, income taxes:(672)(28)43
Other undisclosed income from continuing operations before income taxes 10671
Income (loss) from continuing operations before income taxes:(672)78114
Income tax expense (benefit)112(10)(28)
Net income (loss) available to common stockholders, diluted:(560)6887

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net income (loss):(560)6887
Other comprehensive income (loss)47749(22)
Comprehensive income (loss), net of tax, attributable to parent:(83)11665

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: